drugset
drugset / Trial / NCT01346007

Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome

NCT01346007 ↗

Phase 4 Unknown 50 enrolled National and Kapodistrian University of Athens
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether 7-valent pneumococcal conjugate vaccine safely induces immune responses and immunological memory in children with idiopathic nephrotic syndrome in remission.

Timeline

Start
2009-01
Primary completion
2010-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prevnar 13 Vaccine 0.5 ml —

Indications

idiopathic nephrotic syndrome